Exelixis Inc reports results for the quarter ended in June - Earnings Summary

Exelixis

07/08/2024 04:39

* Exelixis Inc  EXEL.OQ  reported quarterly adjusted
earnings of
84 cents​​ per share for the quarter ended in June, higher than
the same quarter last year, when the company reported EPS of 25
cents.  The mean expectation of twenty analysts for the quarter
was for earnings of 30 cents per share. Wall Street expected
results to range from 23 cents to 36 cents per share.
    * Revenue rose 35.6% to $637.18 million from a year ago;
analysts
expected $465.00 million. 
    * Exelixis Inc's reported EPS for the quarter was 77 cents​.
    * The company reported quarterly net income of $226.12
million.
    * Exelixis Inc shares had risen by 4.7% this quarter and
lost 2.0%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Exelixis Inc is
$27.00 
This summary was machine generated from LSEG data August 7 at
03:38 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.30           0.84           Beat
 Mar. 31 2024      0.24           0.20           Missed
 Dec. 31 2023      0.21           0.27           Beat
 Sep. 30 2023      0.10           0.00           Missed